Momeclir Dosage/Direction for Use

After initial priming of the Mometasone furoate nasal spray pump (10 actuations until a uniform spray is observed), each actuation delivers approximately 100 mg of mometasone furoate suspension containing 50 micrograms mometasone furoate. If the spray pump has not been used for 14 days or longer, it should be reprimed with 2 actuations until a uniform spray is observed, before next use.
Seasonal or Perennial Allergic Rhinitis: Adults (including geriatric patients) and children 12 years of age and older: The usual recommended dose is two actuations (50 micrograms/actuation) in each nostril once daily (total dose 200 micrograms). Once symptoms are controlled, dose reduction to one actuation in each nostril (total dose 100 micrograms) may be effective for maintenance.
If symptoms are inadequately controlled, the dose may be increased to a maximum daily dose of four actuations in each nostril once daily (total dose 400 micrograms). Dose reduction is recommended following control of symptoms.
Children between the ages of 6 and 11 years: The usual recommended dose is one actuation (50 micrograms/actuation) in each nostril once daily (total dose 100 micrograms).
Nasal Polyposis: The usual recommended starting dose for polyposis is two actuations (50 micrograms/actuation) in each nostril once daily (total daily dose of 200 micrograms), if after 5 to 6 weeks symptoms are inadequately controlled the dose may be increased to a daily dose of two sprays in each nostril twice daily (total daily dose of 400 micrograms). The dose should be titrated to the lowest dose at which effective control of symptoms is maintained. If no improvement in symptoms is seen after 5 to 6 weeks of twice daily administration, alternative therapies should be considered.
Efficacy and safety studies of Mometasone furoate (Momeclir) Nasal spray suspension for the treatment of nasal polyposis were four months in duration.
Acute Rhinosinusitis: The usual recommended starting dose for acute rhinosinusitis is two actuations (50 micrograms/actuation) in each nostril twice daily (total dose of 400 micrograms).